The table below shows Stoke Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$184.42M
$36.55M
$8.78M
$12.40M
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$137.92M
$89.13M
$82.23M
$77.84M
$54.17M
$32.20M
SG&A
$67.09M
STOK annual revenue (10-K history)
Stoke Therapeutics, Inc. reported annual revenue of $184.42M for fiscal year 2025. That is up 404.5% from $36.55M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.